➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Medtronic
Dow
Harvard Business School
Merck

Last Updated: March 5, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: BRIVARACETAM

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

BRIVARACETAM

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Ucb Inc BRIVIACT brivaracetam SOLUTION;INTRAVENOUS 205837 NDA UCB, Inc. 50474-970-75 10 VIAL, GLASS in 1 CARTON (50474-970-75) > 5 mL in 1 VIAL, GLASS (50474-970-63)
Ucb Inc BRIVIACT brivaracetam SOLUTION;ORAL 205838 NDA UCB, Inc. 50474-870-15 1 BOTTLE in 1 CARTON (50474-870-15) > 300 mL in 1 BOTTLE
Ucb Inc BRIVIACT brivaracetam TABLET;ORAL 205836 NDA UCB, Inc. 50474-370-66 1 BOTTLE in 1 CARTON (50474-370-66) > 60 TABLET, FILM COATED in 1 BOTTLE
Ucb Inc BRIVIACT brivaracetam TABLET;ORAL 205836 NDA UCB, Inc. 50474-470-09 100 BLISTER PACK in 1 CARTON (50474-470-09) > 1 TABLET, FILM COATED in 1 BLISTER PACK
Ucb Inc BRIVIACT brivaracetam TABLET;ORAL 205836 NDA UCB, Inc. 50474-470-14 1 BLISTER PACK in 1 CARTON (50474-470-14) > 14 TABLET, FILM COATED in 1 BLISTER PACK
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Mallinckrodt
Dow
McKinsey
Colorcon